221 related articles for article (PubMed ID: 12895182)
1. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
Kokjohn K; Bradley M; Griffiths B; Ghannoum M
Int J Dermatol; 2003 Sep; 42 Suppl 1():11-7. PubMed ID: 12895182
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of three topical antimycotics against ring-worm fungi singly and in combination.
Rai MK; Upadhyay SK; Agrawal SC
Hindustan Antibiot Bull; 1992; 34(3-4):104-7. PubMed ID: 1289296
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine.
Gao PH; Cao YB; Xu Z; Zhang JD; Zhang WN; Wang Y; Gu J; Cao YY; Li RY; Jia XM; Jiang YY
Biol Pharm Bull; 2005 Aug; 28(8):1414-7. PubMed ID: 16079485
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model.
Fink S; Burmester A; Hipler UC; Neumeister C; Götz MR; Wiegand C
Microbiologyopen; 2022 Feb; 11(1):e1257. PubMed ID: 35212482
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
Jue SG; Dawson GW; Brogden RN
Drugs; 1985 Apr; 29(4):330-41. PubMed ID: 3158508
[TBL] [Abstract][Full Text] [Related]
8. Broad spectrum antifungal agents in otomycosis.
Bassiouny A; Kamel T; Moawad MK; Hindawy DS
J Laryngol Otol; 1986 Aug; 100(8):867-73. PubMed ID: 3746101
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.
Roques C; Brousse S; Panizzutti C
Mycopathologia; 2006 Dec; 162(6):395-400. PubMed ID: 17146583
[TBL] [Abstract][Full Text] [Related]
10. Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
Wiederhold NP; Fothergill AW; McCarthy DI; Tavakkol A
Antimicrob Agents Chemother; 2014 Jun; 58(6):3553-5. PubMed ID: 24709260
[TBL] [Abstract][Full Text] [Related]
11. Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.
Carrillo-Muñoz AJ; Brió S; Alonso R; del Valle O; Santos P; Quindós G
Int J Antimicrob Agents; 2002 Nov; 20(5):375-9. PubMed ID: 12431873
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of the allylamine derivative terbinafine in vitro.
Petranyi G; Meingassner JG; Mieth H
Antimicrob Agents Chemother; 1987 Sep; 31(9):1365-8. PubMed ID: 3674847
[TBL] [Abstract][Full Text] [Related]
13. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Shehata AS; Mukherjee PK; Ghannoum MA
J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
[TBL] [Abstract][Full Text] [Related]
14. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro.
Nenoff P; Haustein UF; Brandt W
Skin Pharmacol; 1996; 9(6):388-94. PubMed ID: 9055360
[TBL] [Abstract][Full Text] [Related]
16. [In vitro antifungal spectrum of ciclopiroxolamine].
Goudard M; Regli P; Lubrano N
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):621-3. PubMed ID: 2797886
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
Täuber A; Müller-Goymann CC
Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
[TBL] [Abstract][Full Text] [Related]
18. New benzofuran-imidazoles as antimycotic agents. II. In vitro studies.
Riviera L; Bellotti MG; Pestellini V; Giannotti D; Giolitti A; Fantò N
Chemioterapia; 1987 Aug; 6(4):272-6. PubMed ID: 3652278
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
Carrillo-Muñoz AJ; Quindós G; Del Valle O; Santos P; Giusiano G; Guardia C; Eraso E; Ezkurra PA; Tur-Tur C; Hernández-Molina JM
J Chemother; 2008 Aug; 20(4):521-3. PubMed ID: 18676237
[No Abstract] [Full Text] [Related]
20. New imidazole derivates: in-vitro activity on dermatophytes.
Tullio V; Cuffini AM; Carlone NA; Spignoli G
J Chemother; 1991 Jan; 3 Suppl 1():43-6. PubMed ID: 12041784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
